Korean J Pediatr.
2010 Mar;53(3):294-299. 10.3345/kjp.2010.53.3.294.
Clinical application of gonadotropin-releasing hormone analogs in children and adolescents
- Affiliations
-
- 1Department of Pediatrics, College of Medicine, Yonsei University, Seoul, Korea. kimho@yuhs.ac
- KMID: 2281308
- DOI: http://doi.org/10.3345/kjp.2010.53.3.294
Abstract
- Although the increasing incidence of central precocious puberty (CPP) in Korea has recently raised public concerns about health and growth problems, there are many areas of uncertainty regarding the pathogenesis, diagnosis, and management of CPP. In this paper, we review the definition of precocity, the assessment of CPP, and the hormonal abnormalities that support the diagnosis. In addition, we review the practical guidelines regarding the clinical use of gonadotropin-releasing hormone analogs in children with CPP. Indications for treatment, determination of dosage, monitoring during treatment, and discontinuation of therapy are discussed.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Response of Human Chorionic Gonadotropin to 6-D-Trp-Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Stimulation in the Culture Media of Normal Human Placenta of Different Gestational Ages
- The Role of Gonadotropin: Releasing Hormone ( GnRH ) and Its Receptor in the Extrapituitary Tissues
- Application of GnRH agonist in Ob & Gyn
- Indication of Gonadotropin-Releasing Hormone Agonist: Precocious Puberty or Advanced Puberty?
- The effective of ultrashort-term gonadotropin-releasing hormone agonist administration in controlled ovarian hyperstimulation for in vitro fertilization
